Patient characteristics
. | . | . | Medical history . | . | . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Patient . | Sex . | Age, y . | Hemopathy . | Neoplasia . | Others . | Immunosuppression . | Cause of HPS . | Evolution . | |||
1 | F | 48 | No | No | No | CS | Parasite infection | Favorable | |||
2 | M | 15 | No | No | No | No | Viral infection | Favorable | |||
3 | F | 86 | No | Colon | Dermatomyositis | CS | Bacterial infection | Death | |||
4 | M | 42 | No | No | No | No | Viral infection | Favorable | |||
5 | F | 55 | No | No | Still disease | CS and CP | Bacterial infection | Favorable | |||
6 | M | 39 | No | No | No | Chronic ethylic intoxication | Infection (K pneumoniae) | Favorable | |||
7 | M | 59 | No | No | No | No | Viral infection | Favorable | |||
8 | M | 81 | No | No | No | No | Viral infection (HSV) | Favorable | |||
9 | F | 83 | No | No | No | No | Non-Hodgkin lymphoma | Death | |||
10 | M | 83 | No | Prostate | No | No | Metastatic neoplasia | Death | |||
11 | M | 58 | No | No | No | Chronic ethylic intoxication | Viral infection | Favorable | |||
12 | F | 77 | No | No | No | No | Non-Hodgkin lymphoma | Death | |||
13 | M | 62 | No | No | No | No | Viral infection (VZV) | Favorable | |||
14 | M | 62 | No | No | No | No | Non-Hodgkin lymphoma | Death | |||
15 | M | 50 | CLL | No | No | No | Bacterial infection | Favorable | |||
16 | F | 37 | No | No | AIHA | No | Viral infection | Favorable | |||
17 | F | 62 | No | No | No | No | Viral infection | Favorable | |||
18 | M | 61 | No | No | No | No | Nonidentified | Favorable | |||
18 bis | No | No | No | No | Nonidentified | Favorable | |||||
19 | F | 44 | No | No | Chronic hepatitis C | No | Nonidentified | Death | |||
20 | F | 41 | No | No | SLE/RA/APS | CS and splenectomy | Bacterial infection | Favorable |
. | . | . | Medical history . | . | . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Patient . | Sex . | Age, y . | Hemopathy . | Neoplasia . | Others . | Immunosuppression . | Cause of HPS . | Evolution . | |||
1 | F | 48 | No | No | No | CS | Parasite infection | Favorable | |||
2 | M | 15 | No | No | No | No | Viral infection | Favorable | |||
3 | F | 86 | No | Colon | Dermatomyositis | CS | Bacterial infection | Death | |||
4 | M | 42 | No | No | No | No | Viral infection | Favorable | |||
5 | F | 55 | No | No | Still disease | CS and CP | Bacterial infection | Favorable | |||
6 | M | 39 | No | No | No | Chronic ethylic intoxication | Infection (K pneumoniae) | Favorable | |||
7 | M | 59 | No | No | No | No | Viral infection | Favorable | |||
8 | M | 81 | No | No | No | No | Viral infection (HSV) | Favorable | |||
9 | F | 83 | No | No | No | No | Non-Hodgkin lymphoma | Death | |||
10 | M | 83 | No | Prostate | No | No | Metastatic neoplasia | Death | |||
11 | M | 58 | No | No | No | Chronic ethylic intoxication | Viral infection | Favorable | |||
12 | F | 77 | No | No | No | No | Non-Hodgkin lymphoma | Death | |||
13 | M | 62 | No | No | No | No | Viral infection (VZV) | Favorable | |||
14 | M | 62 | No | No | No | No | Non-Hodgkin lymphoma | Death | |||
15 | M | 50 | CLL | No | No | No | Bacterial infection | Favorable | |||
16 | F | 37 | No | No | AIHA | No | Viral infection | Favorable | |||
17 | F | 62 | No | No | No | No | Viral infection | Favorable | |||
18 | M | 61 | No | No | No | No | Nonidentified | Favorable | |||
18 bis | No | No | No | No | Nonidentified | Favorable | |||||
19 | F | 44 | No | No | Chronic hepatitis C | No | Nonidentified | Death | |||
20 | F | 41 | No | No | SLE/RA/APS | CS and splenectomy | Bacterial infection | Favorable |
F indicates female; CS, corticosteroids; M, male; CP, cyclophosphamide; K pneumoniae, Klebsiella pneumoniae; HSV, herpes simplex virus; VZV, varicella zoster virus; CLL, chronic lymphoid leukemia; AIHA, autoimmune hemolytic anemia; SLE, systemic lupus erythematosus; RA, rheumatism arthritis; and APS, antiphospholipid syndrome.